Enhanced inhibition of neuronal ferroptosis and regulation of microglial polarization with multifunctional traditional Chinese medicine active ingredients-based selenium nanoparticles for treating spinal cord injury
Source abstract
Abstract
Spinal cord injury (SCI) is a devastating condition that results in the loss of sensory and motor functions. The complex pathogenesis of SCI contributes to the limited availability of effective therapies. Two major factors exacerbating secondary injury in SCI are neuronal ferroptosis and microglial inflammatory polarization. Tanshinone IIA (TSIIA) has demonstrated a significant anti-ferroptosis effect by inhibiting lipid peroxidation, while tetramethylpyrazine (TMP) exhibits remarkable anti-inflammatory properties by promoting the shift of microglial polarization from the M1 to the M2 phenotype. However, most drugs currently under development primarily target a single aspect of this multifaceted condition, which is insufficient for comprehensive treatment. Selenium nanoparticles have emerged as a promising therapeutic strategy due to their ability to encapsulate various agents, effectively targeting diverse pathophysiological mechanisms while offering favorable water solubility and low toxicity. In this study, we developed a novel nanocarrier functionalized with astragalus polysaccharide (APS) and loaded with TSIIA and TMP. Results from both in vitro and in vivo studies indicate that TSIIA/TMP/APS@Se NPs possess anti-ferroptosis properties and can regulate microglial polarization, potentially enhancing functional recovery following SCI. In summary, this study presents a promising alternative strategy for treating SCI, highlighting its significant potential for future clinical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Circular RNAs in diseases · Ferroptosis and cancer prognosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Global burden of spinal cord injury: future directions10.1016/S1474-4422(23)00366-6 ↗
2. Multifunctional hydrogels loaded with tellurium nanozyme for spinal cord injury repair
3. Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 201910.1016/S1474-4422(23)00287-9 ↗
4. A comprehensive study of gene expression and molecular regulation following spinal cord injury10.1016/j.eng.2019.12.017 ↗
5. Regulation of axonal regeneration after mammalian spinal cord injury10.1038/s41580-022-00562-y ↗
6. High rapamycin-loaded hollow mesoporous Prussian blue nanozyme targets lesion area of spinal cord injury to recover locomotor function10.1016/j.biomaterials.2023.122358 ↗
7. Spinal cord injury: molecular mechanisms and therapeutic interventions10.1038/s41392-023-01477-6 ↗
8. Macrophages dying from ferroptosis promote microglia-mediated inflammatory responses during spinal cord injury10.1016/j.intimp.2024.113281 ↗
9. Ferroptosis is a new therapeutic target for spinal cord injury10.3389/fnins.2023.1136143 ↗
10. Natural products improve organ microcirculation dysfunction following ischemia/reperfusion- and lipopolysaccharide-induced disturbances: mechanistic and therapeutic views10.1016/j.eng.2023.11.016 ↗
11. Ferroptosis: mechanisms, biology and role in disease10.1038/s41580-020-00324-8 ↗
12. Mesenchymal stem cell attenuates spinal cord injury by inhibiting mitochondrial quality control-associated neuronal ferroptosis10.1016/j.redox.2023.102871 ↗
13. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes10.1016/j.abb.2019.108241 ↗
14. The latest view on the mechanism of ferroptosis and its research progress in spinal cord injury10.1155/2020/6375938 ↗
15. Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway10.1111/cns.13657 ↗
16. Restoring neuronal iron homeostasis revitalizes neurogenesis after spinal cord injury10.1073/pnas.2220300120 ↗
17. Microglia in health and diseases: integrative hubs of the central nervous system (CNS)10.1101/cshperspect.a041366 ↗
18. Modulating the polarization phenotype of microglia - a valuable strategy for central nervous system diseases10.1016/j.arr.2023.102160 ↗
19. The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases10.3389/fragi.2023.1231706 ↗
20. Microglial M1/M2 polarization and metabolic states10.1111/bph.13139 ↗
21. Microglia polarization from M1 to M2 in neurodegenerative diseases10.3389/fnagi.2022.815347 ↗
22. Schwann cell-derived exosomes containing MFG-E8 modify macrophage/microglial polarization for attenuating inflammation via the SOCS3/STAT3 pathway after spinal cord injury10.1038/s41419-023-05607-4 ↗
23. Ang-(1-7)/MasR axis promotes functional recovery after spinal cord injury by regulating microglia/macrophage polarization10.1186/s13578-023-00967-y ↗
24. Tofacitinib promotes functional recovery after spinal cord injury by regulating microglial polarization via JAK/STAT signaling pathway10.7150/ijbs.84564 ↗
25. Anti-inflammatory nanotherapeutics by targeting matrix metalloproteinases for immunotherapy of spinal cord injury
26. Recent advances in nanomaterials for the treatment of spinal cord injury
27. Hmox1 is identified as a ferroptosis hub gene and associated with the M1 type microglia/macrophage polarization in spinal cord injury: bioinformatics and experimental validation10.1007/s12035-023-03543-0 ↗
28. Knockout of TNF-α in microglia decreases ferroptosis and convert microglia phenotype after spinal cord injury10.1016/j.heliyon.2024.e36488 ↗
29. Bioactive components of Chinese herbal medicines in the treatment of glucose and lipid metabolism disorders: evidence and potential mechanisms10.1016/j.eng.2023.03.004 ↗
30. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC110.3892/ijmm.2023.5312 ↗
31. Tanshinone protects against spinal cord ischemia-reperfusion injury by inhibiting JNK activity
32. Tetramethylpyrazine promotes axonal remodeling and modulates microglial polarization via JAK2-STAT1/3 and GSK3-NFκB pathways in ischemic stroke10.1016/j.neuint.2023.105607 ↗
33. SIRT1 activation by 2,3,5,6-tetramethylpyrazine alleviates neuroinflammation via inhibiting M1 microglia polarization
34. Synergistic effects of tetramethylpyrazine and astragaloside IV on spinal cord injury via alteration of astrocyte A1/A2 polarization through the Sirt1-NF-κB pathway10.1016/j.intimp.2024.111686 ↗
35. Spinal cord injury and protection10.1016/S0196-0644(85)80064-0 ↗
36. Encapsulation of selenium nanoparticles and metformin in macrophage-derived cell membranes for the treatment of spinal cord injury10.1021/acsbiomaterials.3c01009 ↗
37. Sodium selenite promotes neurological function recovery after spinal cord injury by inhibiting ferroptosis10.4103/1673-5374.314322 ↗
38. Using nutraceuticals to help manage traumatic spinal cord injury
39. Therapeutic applications of selenium nanoparticles10.1016/j.biopha.2018.12.146 ↗
40. Translational selenium nanoparticles to attenuate allergic dermatitis through nrf2-keap1-driven activation of selenoproteins10.1021/acsnano.3c04344 ↗
41. Selenium nanoparticles alleviate renal ischemia/reperfusion injury by inhibiting ferritinophagy via the XBP1/NCOA4 pathway10.1186/s12964-024-01751-2 ↗
42. Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment10.1186/s12951-022-01490-x ↗
43. Polydatin promotes the neuronal differentiation of bone marrow mesenchymal stem cells in vitro and in vivo: involvement of Nrf2 signalling pathway10.1111/jcmm.15187 ↗
44. Extraction of a novel cold-water-soluble polysaccharide from Astragalus membranaceus and its antitumor and immunological activities10.3390/molecules23010062 ↗
45. Preparation and drug release property of tanshinone IIA loaded chitosan-montmorillonite microspheres10.1016/j.ijbiomac.2018.12.072 ↗
46. Dual delivery of tetramethylpyrazine and miR-194-5p using soft mesoporous organosilica nanoparticles for acute lung injury therapy10.2147/IJN.S420802 ↗
47. Novel application of natural anisole compounds as enhancers for transdermal delivery of ligustrazine10.1142/S0192415X15500706 ↗
48. Enhanced mitochondrial targeting and inhibition of pyroptosis with multifunctional metallopolyphenol nanoparticles in intervertebral disc degeneration
49. Customizable dual-fluorescent nanoparticles for tracing and quantifying of cell transport10.2147/IJN.S394953 ↗
50. Selenium attenuates radiation colitis by regulating cGAS-STING signaling10.1002/advs.202403918 ↗
51. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics10.1038/s41565-021-00858-8 ↗
52. TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism10.1016/j.drup.2023.101033 ↗
53. PC-12 cell line as a neuronal cell model for biosensing applications
54. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis10.1016/j.redox.2024.103137 ↗
55. Mechanism of ferroptosis and its role in spinal cord injury
56. A shear-thinning, ROS-scavenging hydrogel combined with dental pulp stem cells promotes spinal cord repair by inhibiting ferroptosis
57. Celastrol inhibits oligodendrocyte and neuron ferroptosis to promote spinal cord injury recovery10.1016/j.phymed.2024.155380 ↗
58. Lipid peroxidation and ferroptosis: the role of GSH and GPx410.1016/j.freeradbiomed.2020.02.027 ↗
59. USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 110.1038/s41418-021-00907-8 ↗
60. Hyperthermia/glutathione-triggered ferritin nanoparticles amplify the ferroptosis for synergistic tumor therapy
61. Fast antioxidation kinetics of glutathione intracellularly monitored by a dual-wire nanosensor10.1002/anie.202313612 ↗
62. Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway10.1016/j.jhazmat.2019.121390 ↗
63. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis10.1007/s00204-023-03476-6 ↗
64. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis10.1016/j.phymed.2023.155135 ↗
65. Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome10.1186/s12958-020-00677-x ↗
66. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation, ALTEX-Altern
67. Microglia coordinate cellular interactions during spinal cord repair in mice10.1038/s41467-022-31797-0 ↗
68. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury10.1186/s12974-020-01973-4 ↗
69. Cytoplasmic escape of mitochondrial DNA mediated by Mfn2 downregulation promotes microglial activation via cGas-sting Axis in spinal cord injury
70. Rewired glycosylation activity promotes scarless regeneration and functional recovery in spiny mice after complete spinal cord transection10.1016/j.devcel.2021.12.008 ↗
71. Bioinformatics analysis of ferroptosis in spinal cord injury10.4103/1673-5374.350209 ↗